China Influenza Medication Market Research Report 2018

Published Date : 2018-02-15

Published By : Qy Research Groups

Category : Pharma & Healthcare

No. of Pages : 106

The global Influenza Medication market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

China plays an important role in global market, with market size of xx million USD in 2016 and will be xx million USD in 2022, with a CAGR of xx%.

This report studies the Influenza Medication development status and future trend in China, focuses on top players in China, also splits Influenza Medication by type and by applications, to fully and deeply research and reveal the market general situation and future forecast.

The major players in China market include
Bristol-Myers Squibb
AstraZeneca
Eli Lilly
Roche
GSK
Novartis
Pfizer
Sanofi
Bayer
Celgene
Seqirus

Geographically, this report splits the China market into six regions,
South China
East China
Southwest China
Northeast China
North China
Central China
Northwest China

On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
Zanamivir
Oseltamivir phosphate
Peramivir
Other Influenza Medication

On the basis of the end users/application, this report covers
adult
kids

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Contents

China Influenza Medication Market Research Report 2017
1 Influenza Medication Overview
1.1 Product Overview and Scope of Influenza Medication
1.2 Classification of Influenza Medication by Product Category
1.2.1 China Influenza Medication Sales (K Units) Comparison by Type (2012-2022)
1.2.2 China Influenza Medication Sales (K Units) Market Share by Type in 2016
1.2.3 Zanamivir
1.2.4 Oseltamivir phosphate
1.2.5 Peramivir
1.2.6 Other Influenza Medication
1.3 China Influenza Medication Market by Application/End Users
1.3.1 China Influenza Medication Sales (K Units) and Market Share Comparison by Applications (2012-2022)
1.3.2 adult
1.3.3 kids
1.4 China Influenza Medication Market by Region
1.4.1 China Influenza Medication Market Size (Million USD) Comparison by Region (2012-2022)
1.4.2 South China Influenza Medication Status and Prospect (2012-2022)
1.4.3 East China Influenza Medication Status and Prospect (2012-2022)
1.4.4 Southwest China Influenza Medication Status and Prospect (2012-2022)
1.4.5 Northeast China Influenza Medication Status and Prospect (2012-2022)
1.4.6 North China Influenza Medication Status and Prospect (2012-2022)
1.4.7 Central China Influenza Medication Status and Prospect (2012-2022)
1.5 China Market Size (Sales and Revenue) of Influenza Medication (2012-2022)
1.5.1 China Influenza Medication Sales (K Units) and Growth Rate (%)(2012-2022)
1.5.2 China Influenza Medication Revenue (Million USD) and Growth Rate (%)(2012-2022)

2 China Influenza Medication Market Competition by Players/Manufacturers
2.1 China Influenza Medication Sales and Market Share of Key Players/Manufacturers (2012-2017)
2.2 China Influenza Medication Revenue and Share by Players/Manufacturers (2012-2017)
2.3 China Influenza Medication Average Price (USD/Unit) by Players/Manufacturers (2012-2017)
2.4 China Influenza Medication Market Competitive Situation and Trends
2.4.1 China Influenza Medication Market Concentration Rate
2.4.2 China Influenza Medication Market Share of Top 3 and Top 5 Players/Manufacturers
2.4.3 Mergers & Acquisitions, Expansion in China Market
2.5 China Players/Manufacturers Influenza Medication Manufacturing Base Distribution, Sales Area, Product Types

3 China Influenza Medication Sales and Revenue by Region (2012-2017)
3.1 China Influenza Medication Sales (K Units) and Market Share by Region (2012-2017)
3.2 China Influenza Medication Revenue (Million USD) and Market Share by Region (2012-2017)
3.3 China Influenza Medication Price (USD/Unit) by Regions (2012-2017)

4 China "&B1&" Sales and Revenue by Type/ Product Category (2012-2017)"
4.1 China Influenza Medication Sales (K Units) and Market Share by Type/ Product Category (2012-2017)
4.2 China Influenza Medication Revenue (Million USD) and Market Share by Type (2012-2017)
4.3 China Influenza Medication Price (USD/Unit) by Type (2012-2017)
4.4 China Influenza Medication Sales Growth Rate (%) by Type (2012-2017)

5 China "&B1&" Sales by Application (2012-2017)"
5.1 China Influenza Medication Sales (K Units) and Market Share by Application (2012-2017)
5.2 China Influenza Medication Sales Growth Rate (%) by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 China Influenza Medication Players/Suppliers Profiles and Sales Data
6.1 Bristol-Myers Squibb
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Influenza Medication Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Bristol-Myers Squibb Influenza Medication Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
6.1.4 Main Business/Business Overview
6.2 AstraZeneca
6.2.1 Company Basic Information, Manufacturing Base and Competitors
6.2.2 Influenza Medication Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 AstraZeneca Influenza Medication Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
6.2.4 Main Business/Business Overview
6.3 Eli Lilly
6.3.1 Company Basic Information, Manufacturing Base and Competitors
6.3.2 Influenza Medication Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Eli Lilly Influenza Medication Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
6.3.4 Main Business/Business Overview
6.4 Roche
6.4.1 Company Basic Information, Manufacturing Base and Competitors
6.4.2 Influenza Medication Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Roche Influenza Medication Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
6.4.4 Main Business/Business Overview
6.5 GSK
6.5.1 Company Basic Information, Manufacturing Base and Competitors
6.5.2 Influenza Medication Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 GSK Influenza Medication Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
6.5.4 Main Business/Business Overview
6.6 Novartis
6.6.1 Company Basic Information, Manufacturing Base and Competitors
6.6.2 Influenza Medication Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Novartis Influenza Medication Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
6.6.4 Main Business/Business Overview
6.7 Pfizer
6.7.1 Company Basic Information, Manufacturing Base and Competitors
6.7.2 Influenza Medication Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Pfizer Influenza Medication Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
6.7.4 Main Business/Business Overview
6.8 Sanofi
6.8.1 Company Basic Information, Manufacturing Base and Competitors
6.8.2 Influenza Medication Product Category, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Sanofi Influenza Medication Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
6.8.4 Main Business/Business Overview
6.9 Bayer
6.9.1 Company Basic Information, Manufacturing Base and Competitors
6.9.2 Influenza Medication Product Category, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Bayer Influenza Medication Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
6.9.4 Main Business/Business Overview
6.10 Celgene
6.10.1 Company Basic Information, Manufacturing Base and Competitors
6.10.2 Influenza Medication Product Category, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Celgene Influenza Medication Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
6.10.4 Main Business/Business Overview
6.11 Seqirus

7 Influenza Medication Manufacturing Cost Analysis
7.1 Influenza Medication Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Influenza Medication

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Influenza Medication Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Influenza Medication Major Manufacturers in 2016
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 China Influenza Medication Market Size (Sales and Revenue) Forecast (2017-2022)
11.1 China Influenza Medication Sales (K Units), Revenue (Million USD) Forecast (2017-2022)
11.2 China Influenza Medication Sales (K Units) Forecast by Type (2017-2022)
11.3 China Influenza Medication Sales (K Units) Forecast by Application (2017-2022)
11.4 China Influenza Medication Sales (K Units) Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List



List of Tables and Figures

Figure Global and China Market Size (Million USD) Comparison (2012-2022)
Table Influenza Medication Sales (K Units) and Revenue (Million USD) Market Split by Product Type
Table Influenza Medication Sales (K Units) by Application (2016-2022)
Figure Product Picture of Influenza Medication
Table China Influenza Medication Sales (K Units) and Growth Rate (%) Comparison by Types (Product Category) (2012-2022)
Figure China Influenza Medication Sales Volume Market Share by Types in 2016
Figure Zanamivir Product Picture
Figure Oseltamivir phosphate Product Picture
Figure Peramivir Product Picture
Figure Other Influenza Medication Product Picture
Figure China Influenza Medication Sales (K Units) Comparison by Application (2012-2022)
Figure China Sales Market Share (%) of Influenza Medication by Application in 2016
Figure adult Examples
Table Key Downstream Customer in adult
Figure kids Examples
Table Key Downstream Customer in kids
Figure South China Influenza Medication Revenue (Million USD) and Growth Rate (2012-2022)
Figure East China Influenza Medication Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest China Influenza Medication Revenue (Million USD) and Growth Rate (2012-2022)
Figure Northeast China Influenza Medication Revenue (Million USD) and Growth Rate (2012-2022)
Figure North China Influenza Medication Revenue (Million USD) and Growth Rate (2012-2022)
Figure Central China Influenza Medication Revenue (Million USD) and Growth Rate (2012-2022)
Figure China Influenza Medication Sales (K Units) and Growth Rate (%)(2012-2022)
Figure China Influenza Medication Revenue (Million USD) and Growth Rate (%)(2012-2022)
Table China Influenza Medication Sales of Key Players/Manufacturers (2012-2017)
Table China Influenza Medication Sales Share (%) by Players/Manufacturers (2012-2017)
Figure 2016 China Influenza Medication Sales Share (%) by Players/Manufacturers
Figure 2017 China Influenza Medication Sales Share (%) by Players/Manufacturers
Table China Influenza Medication Revenue by Players/Manufacturers (2012-2017)
Table China Influenza Medication Revenue Market Share (%) by Players/Manufacturers (2012-2017)
Figure 2016 China Influenza Medication Revenue Market Share (%) by Players/Manufacturers
Figure 2017 China Influenza Medication Revenue Market Share (%) by Players/Manufacturers
Table China Market Influenza Medication Average Price of Key Players/Manufacturers (2012-2017)
Figure China Market Influenza Medication Average Price of Key Players/Manufacturers in 2016
Figure China Influenza Medication Market Share of Top 3 Players/Manufacturers
Figure China Influenza Medication Market Share of Top 5 Players/Manufacturers
Table China Players/Manufacturers Influenza Medication Manufacturing Base Distribution and Sales Area
Table China Players/Manufacturers Influenza Medication Product Category
Table China Influenza Medication Sales (K Units) by Regions (2012-2017)
Table China Influenza Medication Sales Share (%) by Regions (2012-2017)
Figure China Influenza Medication Sales Share (%) by Regions (2012-2017)
Figure China Influenza Medication Sales Market Share (%) by Regions in 2016
Table China Influenza Medication Revenue (Million USD) and Market Share by Regions (2012-2017)
Table China Influenza Medication Revenue Market Share (%) by Regions (2012-2017)
Figure China Influenza Medication Revenue Market Share (%) by Regions (2012-2017)
Figure China Influenza Medication Revenue Market Share (%) by Regions in 2016
Table China Influenza Medication Price (USD/Unit) by Regions (2012-2017)
Table China Influenza Medication Sales (K Units) by Type (2012-2017)
Table China Influenza Medication Sales Share (%) by Type (2012-2017)
Figure China Influenza Medication Sales Share (%) by Type (2012-2017)
Figure China Influenza Medication Sales Market Share (%) by Type in 2016
Table China Influenza Medication Revenue (Million USD) and Market Share by Type (2012-2017)
Table China Influenza Medication Revenue Market Share (%) by Type (2012-2017)
Figure Revenue Market Share of Influenza Medication by Type (2012-2017)
Figure Revenue Market Share of Influenza Medication by Type in 2016
Table China Influenza Medication Price (USD/Unit) by Types (2012-2017)
Figure China Influenza Medication Sales Growth Rate (%) by Type (2012-2017)
Table China Influenza Medication Sales (K Units) by Applications (2012-2017)
Table China Influenza Medication Sales Market Share (%) by Applications (2012-2017)
Figure China Influenza Medication Sales Market Share (%) by Application (2012-2017)
Figure China Influenza Medication Sales Market Share (%) by Application in 2016
Table China Influenza Medication Sales Growth Rate (%) by Application (2012-2017)
Figure China Influenza Medication Sales Growth Rate (%) by Application (2012-2017)
Table Bristol-Myers Squibb Influenza Medication Basic Information List
Table Bristol-Myers Squibb Influenza Medication Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Figure Bristol-Myers Squibb Influenza Medication Sales (K Units) and Growth Rate (%)(2012-2017)
Figure Bristol-Myers Squibb Influenza Medication Sales Market Share (%) in China (2012-2017)
Figure Bristol-Myers Squibb Influenza Medication Revenue Market Share (%) in China (2012-2017)
Table AstraZeneca Influenza Medication Basic Information List
Table AstraZeneca Influenza Medication Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Figure AstraZeneca Influenza Medication Sales (K Units) and Growth Rate (%)(2012-2017)
Figure AstraZeneca Influenza Medication Sales Market Share (%) in China (2012-2017)
Figure AstraZeneca Influenza Medication Revenue Market Share (%) in China (2012-2017)
Table Eli Lilly Influenza Medication Basic Information List
Table Eli Lilly Influenza Medication Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Figure Eli Lilly Influenza Medication Sales (K Units) and Growth Rate (%)(2012-2017)
Figure Eli Lilly Influenza Medication Sales Market Share (%) in China (2012-2017)
Figure Eli Lilly Influenza Medication Revenue Market Share (%) in China (2012-2017)
Table Roche Influenza Medication Basic Information List
Table Roche Influenza Medication Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Figure Roche Influenza Medication Sales (K Units) and Growth Rate (%)(2012-2017)
Figure Roche Influenza Medication Sales Market Share (%) in China (2012-2017)
Figure Roche Influenza Medication Revenue Market Share (%) in China (2012-2017)
Table GSK Influenza Medication Basic Information List
Table GSK Influenza Medication Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Figure GSK Influenza Medication Sales (K Units) and Growth Rate (%)(2012-2017)
Figure GSK Influenza Medication Sales Market Share (%) in China (2012-2017)
Figure GSK Influenza Medication Revenue Market Share (%) in China (2012-2017)
Table Novartis Influenza Medication Basic Information List
Table Novartis Influenza Medication Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Figure Novartis Influenza Medication Sales (K Units) and Growth Rate (%)(2012-2017)
Figure Novartis Influenza Medication Sales Market Share (%) in China (2012-2017)
Figure Novartis Influenza Medication Revenue Market Share (%) in China (2012-2017)
Table Pfizer Influenza Medication Basic Information List
Table Pfizer Influenza Medication Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Figure Pfizer Influenza Medication Sales (K Units) and Growth Rate (%)(2012-2017)
Figure Pfizer Influenza Medication Sales Market Share (%) in China (2012-2017)
Figure Pfizer Influenza Medication Revenue Market Share (%) in China (2012-2017)
Table Sanofi Influenza Medication Basic Information List
Table Sanofi Influenza Medication Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Figure Sanofi Influenza Medication Sales (K Units) and Growth Rate (%)(2012-2017)
Figure Sanofi Influenza Medication Sales Market Share (%) in China (2012-2017)
Figure Sanofi Influenza Medication Revenue Market Share (%) in China (2012-2017)
Table Bayer Influenza Medication Basic Information List
Table Bayer Influenza Medication Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Figure Bayer Influenza Medication Sales (K Units) and Growth Rate (%)(2012-2017)
Figure Bayer Influenza Medication Sales Market Share (%) in China (2012-2017)
Figure Bayer Influenza Medication Revenue Market Share (%) in China (2012-2017)
Table Celgene Influenza Medication Basic Information List
Table Celgene Influenza Medication Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Figure Celgene Influenza Medication Sales (K Units) and Growth Rate (%)(2012-2017)
Figure Celgene Influenza Medication Sales Market Share (%) in China (2012-2017)
Figure Celgene Influenza Medication Revenue Market Share (%) in China (2012-2017)
Table Seqirus Influenza Medication Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Influenza Medication
Figure Manufacturing Process Analysis of Influenza Medication
Figure Influenza Medication Industrial Chain Analysis
Table Raw Materials Sources of Influenza Medication Major Players/Manufacturers in 2016
Table Major Buyers of Influenza Medication
Table Distributors/Traders List
Figure China Influenza Medication Sales (K Units) and Growth Rate (%) Forecast (2017-2022)
Figure China Influenza Medication Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure China Influenza Medication Price (USD/Unit) Trend Forecast (2017-2022)
Table China Influenza Medication Sales (K Units) Forecast by Type (2017-2022)
Figure China Influenza Medication Sales (K Units) Forecast by Type (2017-2022)
Figure China Influenza Medication Sales Volume Market Share Forecast by Type in 2022
Table China Influenza Medication Sales (K Units) Forecast by Application (2017-2022)
Figure China Influenza Medication Sales Volume Market Share Forecast by Application (2017-2022)
Figure China Influenza Medication Sales Volume Market Share Forecast by Application in 2022
Table China Influenza Medication Sales (K Units) Forecast by Regions (2017-2022)
Table China Influenza Medication Sales Volume Share Forecast by Regions (2017-2022)
Figure China Influenza Medication Sales Volume Share Forecast by Regions (2017-2022)
Figure China Influenza Medication Sales Volume Share Forecast by Regions in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Influenza Medication Research Assistance Research Assistance

We will be happy to help you find what you need. Please write to us:

+1-888-236-2744

sales@qyresearchgroups.com